ghk cu face serum Copper Peptide with 1% GHK-Cu peptide, Argireline and Matrixyl 3000 Cu + Peptide Complex Copper Peptide Serum for Face

Published preclinical work often looks at cell migration, blood-vessel signalling, fibroblast activity, epithelial barrier models, and how local tissue environments respond under controlled conditions

In published preclinical work, KPV has been studied for inhibiting NF-B activation in intestinal epithelial cells, with one widely cited study showing PepT1-mediated transport into colonic cells as part of its anti-inflammatory mechanism in mouse colitis models (Dalmasso et al., Gastroenterology , 2008)

Unaddressed inflammation: GHK-Cu is anti-inflammatory, but it works upstream, not against active inflammatory conditions

Always verify the result against your pharmacy label and provider instructions

Eligible patients may use GLOW Blend injections at home after provider instruction